Evidence map›Paper›PMID 30194377›Full record

ArticleEye (London, England)2019

Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination.

Giuseppe Giannaccare, Piera Versura, Francesca Bonifazi, Mariarosaria Sessa, Emilio C Campos

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Eye (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Allogeneic fresh frozen plasma eye drops for the treatment of ocular Graft-versus-Host disease: prospective open-label study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  4. Article
  5. A brief account on ocular graft versus host disease.Indian journal of ophthalmology · 2023
    Review
  6. Article
  7. Article
  8. Update on ocular graft-versus-host disease.Indian journal of ophthalmology · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Giuseppe Giannaccare *Ophthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola- Malpighi University Hospital, Bologna, Italy. giuseppe.giannaccare@gmail.com.
Piera Versura *Ophthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola- Malpighi University Hospital, Bologna, Italy.
Francesca BonifaziHaematology Institute 'L.A. Seragnoli', DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola-Malpighi University Hospital, Bologna, Italy.ORCID http://orcid.org/0000-0003-1544-9911
Mariarosaria SessaHaematology Institute 'L.A. Seragnoli', DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Emilio C CamposOphthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola- Malpighi University Hospital, Bologna, Italy.
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare the proportion and the agreement rate in the diagnosis of chronic ocular graft-versus-host disease (GVHD) among three criteria applied with and without ophthalmological examination before hematopoietic stem cell transplantation (HSCT).

methodsNational Institutes of Health (NIH), International Consensus Criteria on ocular GVHD (ICCGVHD) and TFOS Dry Eye Workshop (DEWS) II criteria were used for the diagnosis of ocular GVHD according to two protocols: ophthalmological examination after HSCT (Protocol A), or before and after HSCT (Protocol B). Proportion of GVHD diagnosis and inter-rate agreement coefficient Kappa (K) among the criteria were calculated.

resultsOne hundred nine patients undergone HSCT were included. NIH, ICCGVHD and DEWS II criteria diagnosed ocular GVHD in 14.7%, 17.4% and 59.6% of the patients (Protocol A), whereas in 11.9%, 15.6% and 33.0% of the HSCT patients (Protocol B). The coefficient K for the proportion of patients diagnosed with ocular GVHD by NIH and ICCGVHD criteria was K = 0.626 (Protocol A) and K = 0.615 (Protocol B). The K coefficient by NIH and DEWS II criteria was K = 0.144 (Protocol A), and K = 0.233 (Protocol B). The K coefficient by ICCGVHD and DEWS II criteria was K = 0.250 (Protocol A) and K = 0.499 (Protocol B). The K coefficient for ocular GVHD diagnosis applying Protocol A and B was K = 0.881 if NIH criteria were used, K = 0.933 if ICCGVHD criteria were used and K = 0.501 if DEWS II criteria were used.

conclusionsThe diagnosis of ocular GVHD varied significantly in our cohort of hematological patients according to both the diagnostic criteria used and the visit protocols applied.

Indexed as

Diagnostic Techniques, OphthalmologicalAdolescentAdultAgedChronic DiseaseConjunctivaDry Eye SyndromesEyelidsFemaleFollow-Up StudiesGraft vs Host DiseaseHematologic DiseasesHematopoietic Stem Cell TransplantationHumansMaleMiddle Aged

Identifiers

PMID30194377
PMCPMC6328533
OpenAlexW2890459102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.